| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 63 |
| 1 | DEXAMETHASONE | 26 |
| 2 | DEXAMETHASONE 1.5 MG | 26 |
| 3 | PREDNISONE | 24 |
| 4 | CLOZAPINE | 21 |
| 5 | ETOPOSIDE | 20 |
| 6 | ACYCLOVIR | 19 |
| 7 | PREDNISOLONE | 17 |
| 8 | PREDNISOLONE ORAL | 17 |
| 9 | PREDNISOLONE ORAL SOLUTION | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DINUTUXIMAB | 3 | 0.0035 |
| 1 | TAFASITAMAB-CXIX | 3 | 0.0033 |
| 2 | DISULFIRAM | 3 | 0.0026 |
| 3 | GLOFITAMAB | 7 | 0.0026 |
| 4 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 5 | ETHACRYNIC ACID | 1 | 0.0018 |
| 6 | CAPLACIZUMAB | 3 | 0.0017 |
| 7 | PRALATREXATE | 1 | 0.0015 |
| 8 | DANAZOL | 4 | 0.0014 |
| 9 | BODY CLEANSER | 1 | 0.0014 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 1 | Aldehyde Dehydrogenase Inhibitor [EPC] | 3 | 0.0026 |
| 2 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 8 | 0.0020 |
| 3 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 4 | Complement Inhibitor [EPC] | 66 | 0.0012 |
| 5 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 13 | 0.0008 |
| 7 | Penem Antibacterial [EPC] | 14 | 0.0004 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 9 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |